Gelesis company
WebMar 10, 2024 · Gelesis Named One of the World’s Most Innovative Companies for 2024 by Fast Company. Boston (March 10, 2024) – Gelesis, a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to the gastrointestinal (GI) tract, has been named to Fast Company’s prestigious annual list … Web2 days ago · Gelesis Holdings Inc does not have a meaningful P/E due to negative earnings over the last 12 trailing months. Gelesis Holdings Inc’s trailing 12-month revenue is $25.8 million with a -368.9% profit margin. ... These three rank figures are added together, and the sum is ranked against the entire stock universe to arrive at a company’s ...
Gelesis company
Did you know?
Web1 day ago · Gelesis Holdings, Inc. operates as a biotechnology company. The firm engages in developing novel category of therapies for weight management and gut related chronic … WebJul 19, 2024 · Gelesis, aConsumer-Focused Biotherapeutics Company and the Maker of Plenity®, to Become a Publicly Traded Company via Merger with Capstar Special Purpose Acquisition Corp. · Building on the successful beta launch of its first product Plenity®, Gelesis aims to transform weight management.
WebThe company develops a hydrogel platform technology to treat obesity and other chronic diseases related to the GI tract. The Gelesis portfolio includes a product for obesity and overweight and a pipeline with potential therapies for Non-alcoholic Fatty Liver Disease, Non-alcoholic Steatohepatitis, Type 2 diabetes and Chronic Idiopathic ... Web2 days ago · BOSTON--(BUSINESS WIRE)--Gelesis Holdings Inc. (NYSE: GLS) (“Gelesis” or the “Company”) the maker of Plenity for weight management, today released new data at Obesity Week in San Diego. 5 months ago - Business Wire. Dr. Frank Greenway to Present Data from the LIGHT-UP Study with Gelesis' Oral Hydrogel Treatment GS200 at Obesity …
WebNov 10, 2024 · Capstar’s sponsor has also agreed to forfeit to Gelesis for cancellation 1,983,750 founders shares at closing, and Capstar will issue a corresponding number of additional shares to Gelesis... WebGelesis Holdings (GLSH) Risk Factors. Public companies are required to disclose risks that can affect the business and impact the stock. These disclosures are known as “Risk …
WebJul 19, 2024 · Biotherapeutics company Gelesis will go public on the New York Stock Exchange through a merger with a special acquisition company, elevating the value of the combined businesses to about $1.3bn.. The partnership with Capstar Special Purpose Acquisition is expected to provide $ 376m in gross proceeds Gelesis needs to fund the …
WebJun 2, 2024 · CE Mark enables Gelesis to market Plenity™ throughout the European Economic Area. BOSTON, June 2, 2024 - Gelesis, a biotechnology company developing a novel hydrogel platform technology to treat obesity and other chronic diseases related to the gastrointestinal (GI) tract, announced today that it has received approval to market … plate poker chipWebApr 9, 2024 · Gelesis Holdings (GLSH) has a Smart Score of N/A based on an analysis of 8 unique data sets, including Analyst Recommendations, Crowd Wisdom, and Hedge Fund … plate profilingWebJul 20, 2024 · Jul 20, 2024. For the second time in six years, weight loss-focused company Gelesis Inc. has eschewed the IPO route. But this time, it's still planning to go public — … pricol share newsWebIn January 2024, Gelesis appointed Inogen Co-Founder and former CFO, Ali Bauerlein, to its board of directors and Audit Committee. Ms. Bauerlein brings success in scaling to over $300 million revenue in a direct-to … pricol softwareWebGelesis is a biotechnology company developing therapies for weight loss and gastrointestinal related diseases. The company develops a hydrogel platform … pricom dream playerWebIn April 2024, Gelesis received FDA clearance for its lead product candidate, Plenity®, as an aid for weight management in overweight and obese adults with a Body Mass Index … pricol share price today live todayWeb2 days ago · Gelesis Holdings Inc’s trailing 12-month revenue is $25.8 million with a -368.9% profit margin. Year-over-year quarterly sales growth most recently was -76.8%. … pricol wiping systems